EMA, new features for the PRIority Medicines (PRIME) scheme
By Giuliana Miglierini Based on the review of results obtained in the first five years of implementation of…
Steps forward towards the new framework for HTA
By Giuliana Miglierini The long-waited European regulation on Health Technology Assessment (HTA) was adopted by the Council of…